Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 2-Phenylpropanal | HCID 7146 | — |
| Reactant | 1H-Indazol-5-amine | HCID 88012 | — |
| Reactant | Sodium Bicarbonate | HCID 516892 | — |
| Reactant | Piperonylamine | HCID 2723901 | — |
| Reactant | Sodium triacetoxyborohydride | HCID 5049666 | — |
| Solvent | Methanol | HCID 887 | — |
| Product | HCID 21098508 | HCID 21098508 | 15.5% |
Reaction Steps
4-Piperidone hydrochloride monohydrate (77 mg) and 2-phenylpropionaldehyde (68 mg) were dissolved in methanol (1 ml), and sodium triacetoxyborohydride (106 mg) was added to the solution. The reaction mixture was stirred at room temperature for 18 hr. 5-Aminoindazole (54 mg) was further added thereto, and the mixture was stirred for 30 min, followed by the addition of borane-pyridine complex (0.05 ml). The reaction mixture was stirred at room temperature for 18 hr. A saturated aqueous sodium hydrogencarbonate solution (1 ml) was then added, and the mixture was extracted with chloroform-propanol (3/1). The organic layer was dried over anhydrous sodium sulfate, and the solvent was removed by distillation under the reduced pressure. The residue was purified by HPLC [chloroform/methanol] to give the title compound (21 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07217722B2 |
|---|
| Source dataset | uspto-grants-2007_05 |
|---|
| ORD ID | ord-b0f3377ea5854dadae582d9e4eaddbbb |
|---|
| Source note | uspto-grants-2007_05 |
|---|